198 related articles for article (PubMed ID: 30324143)
21. Impact of liver-stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct-acting antivirals: A systematic review and time-to-event meta-analysis.
You MW; Kim KW; Shim JJ; Pyo J
J Gastroenterol Hepatol; 2021 Mar; 36(3):601-608. PubMed ID: 32875681
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Serum and Plasma Interleukin-6 Levels in Obstructive Sleep Apnea Syndrome: A Meta-Analysis and Meta-Regression.
Imani MM; Sadeghi M; Khazaie H; Emami M; Sadeghi Bahmani D; Brand S
Front Immunol; 2020; 11():1343. PubMed ID: 32793188
[TBL] [Abstract][Full Text] [Related]
23. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.
Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S
Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk.
Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto S; Handajani R
J Viral Hepat; 2021 Jan; 28(1):61-71. PubMed ID: 32896077
[TBL] [Abstract][Full Text] [Related]
25. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
[TBL] [Abstract][Full Text] [Related]
26. Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.
Zhou X; Zhang T; Sun Y; Li C; Ding X; Zhu Y; Li L; Fan Z
Front Pharmacol; 2022; 13():764854. PubMed ID: 35300300
[No Abstract] [Full Text] [Related]
27. The Different Prognoses of Hepatocellular Carcinoma with Previous Tenofovir versus Entecavir Treatment for Chronic Hepatitis B Virus: Analysis Based on 15 Propensity Score-Matched Studies.
Hou J; Qiang Z; Li Y; Zhang Y
Dig Dis; 2023; 41(3):476-488. PubMed ID: 36535244
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis.
Huang Y; Chen Y; Tu S; Zhang J; Qiu Y; Yu W
BMC Infect Dis; 2022 Apr; 22(1):323. PubMed ID: 35365115
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
[TBL] [Abstract][Full Text] [Related]
30. Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development.
Nassar ES; Elkalbashawy YA; Kamal A; Zakaria NHE
Clin Exp Hepatol; 2021 Mar; 7(1):74-78. PubMed ID: 34027118
[TBL] [Abstract][Full Text] [Related]
31. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.
Liu F; Wang XW; Chen L; Hu P; Ren H; Hu HD
Aliment Pharmacol Ther; 2016 Jun; 43(12):1253-61. PubMed ID: 27117732
[TBL] [Abstract][Full Text] [Related]
32. Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis.
An Y; Xu S; Liu Y; Xu X; Philips CA; Chen J; Méndez-Sánchez N; Guo X; Qi X
Front Med (Lausanne); 2021; 8():744518. PubMed ID: 34778306
[No Abstract] [Full Text] [Related]
33. The association of serum IL-33/ST2 expression with hepatocellular carcinoma.
Pan X; Liu J; Li M; Liang Y; Liu Z; Lao M; Fang M
BMC Cancer; 2023 Jul; 23(1):704. PubMed ID: 37507682
[TBL] [Abstract][Full Text] [Related]
34. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
[TBL] [Abstract][Full Text] [Related]
35. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.
Bhagavathula AS; Woolf B; Rahmani J; Vidyasagar K; Tesfaye W
Eur J Clin Pharmacol; 2022 Apr; 78(4):547-555. PubMed ID: 35039907
[TBL] [Abstract][Full Text] [Related]
36. Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis: A meta-analysis of randomized controlled trials.
Qu LS; Chen H; Kuai XL; Xu ZF; Jin F; Zhou GX
Hepatol Res; 2012 Aug; 42(8):782-9. PubMed ID: 22414050
[TBL] [Abstract][Full Text] [Related]
37. Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis.
Zhu SL; Zhong JH; Gong WF; Li H; Li LQ
Onco Targets Ther; 2016; 9():2111-9. PubMed ID: 27143913
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between CD4+CD25+Treg cells, Th17 cells and IL-6 and the prognosis of hepatitis B virus-related acute-on-chronic liver failure: a meta-analysis].
Lv H; Pan Z; Hu S; Chen Y; Zhuang Q; Yao X; Xu L; Xiao Z; Qiu L
Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):493-8. PubMed ID: 25203799
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.
Soresi M; Giannitrapani L; D'Antona F; Florena AM; La Spada E; Terranova A; Cervello M; D'Alessandro N; Montalto G
World J Gastroenterol; 2006 Apr; 12(16):2563-8. PubMed ID: 16688802
[TBL] [Abstract][Full Text] [Related]
40. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinoma：a meta-analysis.
Zhang H; Ding R; Chen D
Biomarkers; 2021 Nov; 26(7):586-597. PubMed ID: 34266326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
